Influence of the initial venous thrombo-embolism event on outcome in patients with COPD: Findings from the RIETE registry

L. Bertoletti, S. Quenet, S. Laporte, L. Hernandez, J. J. Martin-Villasclaras, C. Tolosa, M. Valdes, M. Barron, J. Todoli, M. Monreal (Saint-Etienne, France; Alicante, Malaga, Sabadell, Viladencans, Logroño, Valencia, Spain)

Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Session: Prediction of pulmonary thromboembolism
Session type: Thematic Poster Session
Number: 3950
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Bertoletti, S. Quenet, S. Laporte, L. Hernandez, J. J. Martin-Villasclaras, C. Tolosa, M. Valdes, M. Barron, J. Todoli, M. Monreal (Saint-Etienne, France; Alicante, Malaga, Sabadell, Viladencans, Logroño, Valencia, Spain). Influence of the initial venous thrombo-embolism event on outcome in patients with COPD: Findings from the RIETE registry. Eur Respir J 2011; 38: Suppl. 55, 3950

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study
Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017
Year: 2017



Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021
Year: 2022



Prognostic impact of acute kidney injury in patients with acute pulmonary embolism.Data from the RIETE registry
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010


Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry
Source: Eur Respir J, 53 (2) 1801677; 10.1183/13993003.01677-2018
Year: 2019



Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019
Year: 2020



Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017
Year: 2018



Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden
Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016
Year: 2017



A retrospective cohort study of patients with pulmonary embolism: the impact of comorbidities on patient's outcome
Source: Eur Respir J 2016; 48: 555-557
Year: 2016


Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017

Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021
Year: 2021



Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021



Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study
Source: Eur Respir J 2014; 43: 801-807
Year: 2014



Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017



Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry
Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018
Year: 2018



Hispanic patients with pulmonary arterial hypertension: Preliminary results from a contemporary national registry
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017